These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25884459)

  • 41. Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.
    Pacheco-Lugo L; Sáenz-García J; Navarro Quiroz E; González Torres H; Fang L; Díaz-Olmos Y; Garavito de Egea G; Egea Bermejo E; Aroca Martínez G
    Lupus; 2019 Jan; 28(1):34-43. PubMed ID: 30453818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.
    Yap DY; Yung S; Zhang Q; Tang C; Chan TM
    Lupus; 2016 Jan; 25(1):46-53. PubMed ID: 26251400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urine biomarkers in juvenile-onset SLE nephritis.
    Watson L; Beresford MW
    Pediatr Nephrol; 2013 Mar; 28(3):363-74. PubMed ID: 22588674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.
    Morell M; Pérez-Cózar F; Marañón C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
    Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
    Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum uric acid levels are associated with lupus nephritis in patients with normal renal function.
    Calich AL; Borba EF; Ugolini-Lopes MR; da Rocha LF; Bonfá E; Fuller R
    Clin Rheumatol; 2018 May; 37(5):1223-1228. PubMed ID: 29353328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary CXCL10: a marker of nephritis in lupus patients.
    Marie MA; Abu Khalil RE; Habib HM
    Reumatismo; 2014 Mar; 65(6):292-7. PubMed ID: 24705033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
    Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noninvasive biomarkers for lupus nephritis.
    Liu T; Yang YL; Zhou Y; Jiang YM
    Lab Med; 2024 Sep; 55(5):535-542. PubMed ID: 38493322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complement 1q (C1q) antibodies levels in sera of Egyptian patients with lupus nephritis.
    Elshweikh SA; Elkhouly RM; Shaalan MM; Shorbagy SH
    Egypt J Immunol; 2014; 21(2):49-59. PubMed ID: 25812352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
    Gupta R; Yadav A; Aggarwal A
    Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy.
    Bona N; Pezzarini E; Balbi B; Daniele SM; Rossi MF; Monje AL; Basiglio CL; Pelusa HF; Arriaga SMM
    Lupus; 2020 Mar; 29(3):311-323. PubMed ID: 32063098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.
    Howe HS; Kong KO; Thong BY; Law WG; Chia FL; Lian TY; Lau TC; Chng HH; Leung BP
    Int J Rheum Dis; 2012 Feb; 15(1):13-6. PubMed ID: 22324942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.
    Avihingsanon Y; Phumesin P; Benjachat T; Akkasilpa S; Kittikowit V; Praditpornsilpa K; Wongpiyabavorn J; Eiam-Ong S; Hemachudha T; Tungsanga K; Hirankarn N
    Kidney Int; 2006 Feb; 69(4):747-53. PubMed ID: 16518330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
    Alzawawy A; Zohary M; Ablordiny M; Eldalie M
    Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.
    Birmingham DJ; Irshaid F; Nagaraja HN; Zou X; Tsao BP; Wu H; Yu CY; Hebert LA; Rovin BH
    Lupus; 2010 Oct; 19(11):1272-80. PubMed ID: 20605879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
    Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
    Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.
    Brugos B; Kiss E; Dul C; Gubisch W; Szegedi G; Sipka S; Zeher M
    Hum Immunol; 2010 Sep; 71(9):874-7. PubMed ID: 20538031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.